FORN EUROPAR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.7 USD | +1.29% |
|
+6.08% | -27.63% |
Financials (USD)
| Sales 2021 | - | Sales 2022 | - | Capitalization | 163M |
|---|---|---|---|---|---|
| Net income 2021 | - | Net income 2022 | - | EV / Sales 2021 * | - |
| Net cash position 2021 | 1.07M | Net cash position 2022 | 314K | EV / Sales 2022 | - |
| P/E ratio 2021 * |
-
| P/E ratio 2022 |
5,317
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.29% | ||
| Current month | -27.63% | ||
| 6 months | -30.44% | ||
| Current year | -27.63% |
1 year
9.25
47.17
3 years
9.2547.17
5 years
9.2547.17
10 years
9.2547.17
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 15.7 | +1.29% | 172,175 |
| 24-04-26 | 15.5 | +5.30% | 113,407 |
| 24-04-25 | 14.72 | -0.20% | 48,417 |
| 24-04-24 | 14.75 | -3.34% | 36,349 |
| 24-04-23 | 15.26 | +3.11% | 51,307 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotes
Forbion European Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination. The Company intend to focus its search on lifestyle, technology, healthcare and wellness sectors. The Company has not commenced any operations nor generated any revenue.
Sector
-
- Stock Market
- Equities
- FRBN Stock
